Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV I Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00001005
What this trial is testing

Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT00363142
What this trial is testing

An Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
GlaxoSmithKline 211
Early research (Phase 1)Study completedNCT05144386
What this trial is testing

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

Who this might be right for
HIV-1-infection
Excision BioTherapeutics 6
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableStudy completedNCT00000634
What this trial is testing

A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Early research (Phase 1)Study completedNCT04802811
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects

Who this might be right for
HIV-1 Infection
Jiangsu HengRui Medicine Co., Ltd. 37
Early research (Phase 1)Study completedNCT02599896
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
Prevention of HIV InfectionHIV AntibodiesMonoclonal Antibody, Human+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableStudy completedNCT00351442
What this trial is testing

Examining Factors That May Influence Resistance to HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 522
Early research (Phase 1)Study completedNCT00000972
What this trial is testing

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 64
Early research (Phase 1)UnknownNCT02762045
What this trial is testing

Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine

Who this might be right for
Acquired Immunodeficiency Syndrome
Centers for Disease Control and Prevention, China 36
Early research (Phase 1)Study completedNCT00001112
What this trial is testing

The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Not applicableStudy completedNCT03579381
What this trial is testing

Specimen Repository for HIV Immunopathogenesis

Who this might be right for
HIV-1-infectionAcute HIV Infection
AIDS Healthcare Foundation 9
Post-approval studies (Phase 4)Study completedNCT04553081
What this trial is testing

2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial

Who this might be right for
HIV-1-infection
University Hospital, Ghent 134
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Large-scale testing (Phase 3)Study completedNCT00454337
What this trial is testing

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 170
Testing effectiveness (Phase 2)Study completedNCT00251537
What this trial is testing

A Pilot Study of LTB4 in HIV-1 Infected Adults

Who this might be right for
HIV Infections
LTB4 Sweden AB 40
Early research (Phase 1)Study completedNCT00069030
What this trial is testing

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 70
Early research (Phase 1)Study completedNCT00000839
What this trial is testing

A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT00002012
What this trial is testing

Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients

Who this might be right for
HIV Infections
Interferon Sciences 45
Large-scale testing (Phase 3)Study completedNCT00158457
What this trial is testing

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 40
Next Page